BeOne Medicines (ONC) EBITDA (2015 - 2026)
BeOne Medicines' (ONC) quarterly EBITDA came in at $325.0 million in Q2 2026, up 269.85% year-over-year from $87.9 million in Q2 2025, and up 30.07% quarter-over-quarter from $249.9 million in Q1 2026.
Powered by 
Analysis
BeOne Medicines (ONC) EBITDA (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported EBITDA for 12 consecutive years, with $325.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA rose 269.85% year-over-year to $325.0 million in Q2 2026; TTM through Jun 2026 was $923.1 million, a 1016.65% increase from a year earlier, with the FY2025 full-year figure at $447.1 million, up 178.69% from the prior year.
- EBITDA was $325.0 million for Q2 2026 at BeOne Medicines, up from $249.9 million in the prior quarter.
- Over five years, EBITDA peaked at $325.0 million in Q2 2026 and troughed at -$468.6 million in Q4 2022.
- A 5-year average of -$141.3 million and a median of -$127.1 million in 2023 frame the typical range for EBITDA.
- Across the five-year window, EBITDA plunged 731.76% in 2022 and surged 2150.96% in 2026, its largest moves.
- Over 5 years, EBITDA stood at -$468.6 million in 2022, then rose by 18.1% to -$383.8 million in 2023, then surged by 79.31% to -$79.4 million in 2024, then surged by 332.97% to $185.0 million in 2025, then surged by 75.67% to $325.0 million in 2026.
- The last three EBITDA figures came in at $325.0 million (Q2 2026), $249.9 million (Q1 2026), and $185.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.25 Bn |
| 10 | BeOne Medicines | 41.25 Bn | 36.15 Bn | 1.53 Bn | 325.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 325.05 Mn |
| Mar 31, 2026 | 249.90 Mn |
| Dec 31, 2025 | 185.04 Mn |
| Sep 30, 2025 | 163.11 Mn |
| Jun 30, 2025 | 87.89 Mn |
| Mar 31, 2025 | 11.10 Mn |
| Dec 31, 2024 | -79.43 Mn |
| Sep 30, 2024 | -120.27 Mn |
| Jun 30, 2024 | -107.16 Mn |
| Mar 31, 2024 | -261.35 Mn |
| Dec 31, 2023 | -383.80 Mn |
| Sep 30, 2023 | -133.97 Mn |
| Jun 30, 2023 | -318.72 Mn |
| Mar 31, 2023 | -371.26 Mn |
| Dec 31, 2022 | -468.62 Mn |
| Sep 30, 2022 | -438.36 Mn |
| Jun 30, 2022 | -439.40 Mn |
| Mar 31, 2022 | -443.29 Mn |
| Dec 31, 2021 | -571.74 Mn |
| Sep 30, 2021 | -462.33 Mn |
API Access
BeOne Medicines EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ONC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ONC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ONC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();